|
US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
|
EP1013275A3
(en)
*
|
1991-11-26 |
2001-01-10 |
Sepracor, Inc. |
Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
|
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
|
AT399718B
(de)
*
|
1992-04-16 |
1995-07-25 |
Lek Tovarna Farmacevtskih |
Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
|
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
|
USRE39384E1
(en)
|
1993-09-01 |
2006-11-07 |
Smithkline Beecham P.L.C. |
Substituted thiazolidinedione derivatives
|
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
FI973691A0
(fi)
|
1995-03-16 |
1997-09-15 |
Pfizer |
Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
|
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
|
WO1999018957A1
(en)
*
|
1998-03-26 |
1999-04-22 |
Reddy-Cheminor, Inc. |
Stable pharmaceutical composition containing amlodipine besylate and atenolol
|
|
RU2188636C2
(ru)
*
|
1998-03-26 |
2002-09-10 |
Др. Редди'С Лабораторис Лтд. |
Стабильный фармацевтический препарат, содержащий амлодипина безилат и атенолол
|
|
PL189666B1
(pl)
*
|
1998-04-09 |
2005-09-30 |
Adamed Sp Z Oo |
Sposób otrzymywania benzenosulfonianu amlodypiny
|
|
ATE371448T1
(de)
|
1998-07-10 |
2007-09-15 |
Novartis Pharma Gmbh |
Bluthochdruckgegenmittelkombination des valsartan und kalziumkanal blocker
|
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
|
US20070072828A1
(en)
*
|
1998-07-24 |
2007-03-29 |
Yoo Seo H |
Bile preparations for colorectal disorders
|
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
|
UA33033A
(uk)
*
|
1998-10-16 |
2001-02-15 |
Др.Редіс Леборетрис Лтд |
Спосіб одержання безилату амлодипіну
|
|
US7129265B2
(en)
*
|
1999-04-23 |
2006-10-31 |
Mason R Preston |
Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
|
|
RU2142942C1
(ru)
*
|
1999-04-28 |
1999-12-20 |
Дж. Б.Кемикалс энд Фармасьютикалс Лтд. |
Способ получения монобензолсульфоната 3-этил-5-метилового эфира 2-[(2-аминоэтокси)метил]-4-(2-хлорфенил)-1,4-дигидро-6-метил-3,5-пиридинди карбоновой кислоты
|
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
|
CN1352640A
(zh)
|
1999-05-27 |
2002-06-05 |
辉瑞产品公司 |
氨氯地平和阿托伐他汀的共同前体药物
|
|
RU2161156C1
(ru)
*
|
1999-06-01 |
2000-12-27 |
Джи.Б.Кемикалс Энд Фармасьютикалс Лтд |
Способ получения 3-этил-5-метиловый эфир 2-[2-(n-фталимидо)-этоксиметил]-4-(2-хлорфенил)-1,4-дигидро-6-метил-3,5- пиридиндикарбоновой кислоты
|
|
UA72768C2
(en)
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
|
RU2146672C1
(ru)
*
|
1999-10-13 |
2000-03-20 |
Др.Редди'С Лабораторис Лтд. |
Способ получения 3-этил-5-метил(±)2[2-аминоэтокси)-метил]-4-(2-хлорфенил)-1,4-дигидро- 6-метил-3,5-пиридиндикарбоксилат монобензолсульфоната
|
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
|
WO2002011723A1
(en)
|
2000-08-04 |
2002-02-14 |
Mason R Preston |
Synergistic effect of amlodipine and atorvastatin
|
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
|
US6653481B2
(en)
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
|
EP1346214A2
(en)
*
|
2000-12-29 |
2003-09-24 |
Pfizer Limited |
Reference standards and processes for determining the purity or stability of amlodipine maleate
|
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
|
WO2002053540A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Aspartate derivative of amlodipine as calcium channel antagonist
|
|
BR0116552A
(pt)
|
2000-12-29 |
2004-02-03 |
Pfizer Ltd |
Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão
|
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
|
CA2433181C
(en)
|
2000-12-29 |
2005-11-22 |
Pfizer Limited |
Amlodipine hemifumarate
|
|
BR0116554A
(pt)
|
2000-12-29 |
2004-02-03 |
Pfizer Ltd |
Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
|
|
CN1272319C
(zh)
|
2000-12-29 |
2006-08-30 |
辉瑞有限公司 |
制备氨氯地平马来酸盐的工艺、所制得的氨氯地平马来酸盐、其药物组合物和用途
|
|
DK1221438T3
(da)
*
|
2001-01-09 |
2007-06-18 |
Siegfried Generics Int Ag |
Salte af Amlodipinmesylat
|
|
GB0103046D0
(en)
|
2001-02-07 |
2001-03-21 |
Novartis Ag |
Organic Compounds
|
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
|
US20030027848A1
(en)
*
|
2001-06-15 |
2003-02-06 |
Anne Billotte |
Stabilized formulations
|
|
WO2003004025A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Lek Pharmaceutical And Chemical Company D.D. |
High purity amlodipine benzenesulfonate and a process for its preparation
|
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
|
AR037565A1
(es)
*
|
2001-11-21 |
2004-11-17 |
Synthon Bv |
Formas de sales de amlodipina y procedimientos para prepararlas.
|
|
HU226642B1
(en)
*
|
2001-12-17 |
2009-05-28 |
Egis Gyogyszergyar Nyilvanosan |
Amlodipine bezylate tablets having extended stability and process for producing the same
|
|
NL1019882C2
(nl)
*
|
2002-02-01 |
2003-08-04 |
Synthon Licensing |
Amlodipine vrije base.
|
|
EP1499592A4
(en)
*
|
2002-04-13 |
2010-01-13 |
Hanlim Pharmaceutical Co Ltd |
AMLODIPINE NICOTINATE AND PROCESS FOR PREPARING THE SAME
|
|
NZ536467A
(en)
|
2002-05-06 |
2006-11-30 |
Endocyte Inc |
Vitamin-targeted imaging agents
|
|
EG24716A
(en)
|
2002-05-17 |
2010-06-07 |
Novartis Ag |
Combination of organic compounds
|
|
SI21233A
(sl)
*
|
2002-05-31 |
2003-12-31 |
LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. |
Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba
|
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
|
RU2221784C1
(ru)
*
|
2002-07-05 |
2004-01-20 |
Марвел Лайфсайнсез Прайвит Лимитед |
Способ получения бензолсульфоната амлодипина
|
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
|
KR100538641B1
(ko)
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
|
KR100496436B1
(ko)
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
|
KR100462304B1
(ko)
*
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
|
KR100467669B1
(ko)
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
|
EP1535907A4
(en)
|
2002-08-29 |
2006-11-29 |
Taisho Pharmaceutical Co Ltd |
BENZOLSULFONATE OF A 4-FLUORO-2-CYANOPYRROLIDINE DERIVATIVE
|
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
|
WO2004024690A1
(en)
|
2002-09-11 |
2004-03-25 |
Hanlim Pharmaceutical Co., Ltd. |
S-(-)-amlodipine nicotinate and process for the preparation thereof
|
|
AU2003253460A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
|
US7166641B2
(en)
*
|
2002-10-02 |
2007-01-23 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
|
|
EP1407773A1
(en)
*
|
2002-10-08 |
2004-04-14 |
Council of Scientific and Industrial Research |
A process for the preparation of s (-) amlodipine salts
|
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
|
WO2004058711A1
(en)
*
|
2002-12-30 |
2004-07-15 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
|
BRPI0407038A
(pt)
|
2003-01-27 |
2006-01-17 |
Hanmi Pharm Ind Co Ltd |
Camsilato de amlodipina amorfo estável, processo para a preparação do mesmo e composição para administração oral deste
|
|
JP3874419B2
(ja)
|
2003-01-31 |
2007-01-31 |
三共株式会社 |
動脈硬化及び高血圧症の予防及び治療のための医薬
|
|
KR20040072363A
(ko)
*
|
2003-02-12 |
2004-08-18 |
주식회사 대웅 |
신규한 암로디핀 사이클라메이트 염 및 그의 제조방법
|
|
WO2004075825A2
(en)
*
|
2003-02-28 |
2004-09-10 |
Ranbaxy Laboratories Limited |
Dosage forms of amlodipine and processes for their preparation
|
|
EP1618111B1
(en)
|
2003-04-25 |
2014-12-24 |
Cadila Healthcare Limited |
Salts of clopidogrel and process for preparation
|
|
DE112004000712T5
(de)
*
|
2003-04-25 |
2006-10-19 |
Cipla Ltd. |
Verfahren zur Herstellung von Amlodipinmesilat-Monohydrat
|
|
WO2004103960A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
|
KR20110117731A
(ko)
|
2003-05-30 |
2011-10-27 |
랜박시 래보러터리스 리미티드 |
치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
|
|
RU2239433C1
(ru)
*
|
2003-06-09 |
2004-11-10 |
Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" |
Лекарственная форма, обладающая вазодилатирующим, антиангинальным, гипотензивным и спазмолитическим действием, и способ ее изготовления
|
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
|
US20050048118A1
(en)
*
|
2003-07-25 |
2005-03-03 |
Joan Cucala Escoi |
Modified release venlafaxine hydrochloride tablets
|
|
WO2005042485A1
(en)
*
|
2003-10-30 |
2005-05-12 |
Sk Chemicals, Co., Ltd. |
Acid added salts of amlodipine
|
|
KR100841409B1
(ko)
*
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
WO2005089353A2
(en)
*
|
2004-03-16 |
2005-09-29 |
Sepracor Inc. |
(s)-amlodipine malate
|
|
PL1750862T3
(pl)
|
2004-06-04 |
2011-06-30 |
Teva Pharma |
Kompozycja farmaceutyczna zawierająca irbesartan
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
JP2008511651A
(ja)
*
|
2004-08-30 |
2008-04-17 |
セオ ホン ユー |
局所虚血モデルでの可溶化ｕｄｃａの神経保護効果
|
|
AU2005295541B2
(en)
*
|
2004-10-15 |
2011-02-17 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
|
CA2585471A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
|
EP1819681B1
(en)
*
|
2004-11-23 |
2009-08-12 |
Warner-Lambert Company LLC |
7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
|
WO2006059217A1
(en)
*
|
2004-12-01 |
2006-06-08 |
Ranbaxy Laboratories Limited |
Stable solid dosage forms of amlodipine besylate and processes for their preparation
|
|
WO2006070248A1
(en)
*
|
2004-12-28 |
2006-07-06 |
Ranbaxy Laboratories Limited |
Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
|
|
WO2006085208A2
(en)
*
|
2005-02-11 |
2006-08-17 |
Ranbaxy Laboratories Limited |
Stable solid dosage forms of amlodipine and benazepril
|
|
WO2006131923A2
(en)
*
|
2005-06-07 |
2006-12-14 |
Ramot At Tel Aviv University Ltd. |
Novel salts of conjugated psychotropic drugs and processes of preparing same
|
|
KR20130135994A
(ko)
*
|
2005-06-27 |
2013-12-11 |
다이이찌 산쿄 가부시키가이샤 |
안지오텐신 ⅱ 수용체 길항제 및 칼슘 채널 차단제를 함유한 약학 제제
|
|
US8158146B2
(en)
|
2005-09-28 |
2012-04-17 |
Teva Pharmaceutical Industries Ltd. |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
|
DE602005005706T2
(de)
*
|
2005-09-28 |
2009-04-16 |
Teva Pharmaceutical Industries Ltd. |
Stabile Arzneimittelkombinationen von Amlodipinbesylat und Benazeprilhydrochlorid
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
SG166829A1
(en)
|
2005-11-08 |
2010-12-29 |
Ranbaxy Lab Ltd |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
FR2894826B1
(fr)
*
|
2005-12-21 |
2010-10-22 |
Servier Lab |
Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
|
|
WO2008010222A2
(en)
|
2006-07-17 |
2008-01-24 |
Ramot At Tel Aviv University Ltd. |
Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders
|
|
KR100795313B1
(ko)
|
2006-09-05 |
2008-01-21 |
현대약품 주식회사 |
암로디핀 베실레이트를 포함하는 약학 조성물
|
|
TWI399223B
(zh)
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
|
JP5498168B2
(ja)
|
2006-12-01 |
2014-05-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
|
|
CA2673336A1
(en)
*
|
2006-12-21 |
2008-06-26 |
Xenoport, Inc. |
Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
|
|
EP2109447B1
(en)
|
2007-01-29 |
2015-06-10 |
HanAll Biopharma Co., Ltd. |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
|
WO2008124121A1
(en)
*
|
2007-04-06 |
2008-10-16 |
Scidose, Llc |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
|
US8748648B2
(en)
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
|
US8143314B1
(en)
*
|
2007-09-13 |
2012-03-27 |
Robert Carl Stover |
Methods and formulations for treating ineffective or decreased esophageal motility
|
|
KR101226669B1
(ko)
*
|
2007-09-21 |
2013-01-25 |
한올바이오파마주식회사 |
Ｎ,ｎ－디메틸 이미도디카르본이미딕 디아미드의 디카르복실산염, 그의 제조 방법 및 그의 약제학적 조성물
|
|
WO2009084003A1
(en)
|
2007-12-31 |
2009-07-09 |
Lupin Limited |
Pharmaceutical compositions of amlodipine and valsartan
|
|
US8207369B2
(en)
|
2008-02-11 |
2012-06-26 |
Ramot At Tel-Aviv University Ltd. |
Conjugates for treating neurodegenerative diseases and disorders
|
|
RU2359672C1
(ru)
*
|
2008-02-18 |
2009-06-27 |
Зао "Биоком" |
Твердая лекарственная форма, предназначенная для лечения артериальной гипертензии и стенокардии, и способ ее получения
|
|
CN101564536B
(zh)
*
|
2008-04-21 |
2010-12-15 |
鲁南制药集团股份有限公司 |
一种治疗高血压的药物组合物缓控释制剂
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
TWI458721B
(zh)
|
2008-06-27 |
2014-11-01 |
Celgene Avilomics Res Inc |
雜芳基化合物及其用途
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
CN102186804A
(zh)
*
|
2008-10-20 |
2011-09-14 |
克塞诺波特公司 |
合成左旋多巴酯前药的方法
|
|
US8399513B2
(en)
|
2008-10-20 |
2013-03-19 |
Xenoport, Inc. |
Levodopa prodrug mesylate hydrate
|
|
WO2010070705A1
(ja)
*
|
2008-12-17 |
2010-06-24 |
株式会社メドレックス |
アムロジピンの安定な含水経口製剤
|
|
ES2580777T3
(es)
|
2009-01-23 |
2016-08-26 |
Hanmi Holdings Co., Ltd. |
Composición farmacéutica sólida que comprende amlodipino y losartán y procedimiento para producir la misma
|
|
JP2013520521A
(ja)
*
|
2009-11-09 |
2013-06-06 |
ゼノポート，インコーポレーテッド |
レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法
|
|
CA2782514A1
(en)
|
2009-12-09 |
2011-06-16 |
Biolinerx Ltd. |
Methods of improving cognitive functions
|
|
EP3150610B1
(en)
|
2010-02-12 |
2019-07-31 |
Pfizer Inc |
Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
|
|
EP2539857A4
(en)
|
2010-02-24 |
2013-07-24 |
Univ Ramot |
CRYSTALLINE FORMS OF TRI MESYLATE SALT OF PERPHENAZINE GABA AND METHOD OF MANUFACTURING THEREOF
|
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
|
IT1400309B1
(it)
*
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
|
EP2425859A1
(en)
|
2010-08-08 |
2012-03-07 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Olmesartan formulations
|
|
KR20130099040A
(ko)
*
|
2010-08-10 |
2013-09-05 |
셀진 아빌로믹스 리서치, 인코포레이티드 |
Ｂｔｋ 억제제의 베실레이트 염
|
|
US8916610B2
(en)
|
2010-09-22 |
2014-12-23 |
Ramot At Tel-Aviv University Ltd. |
Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
|
|
ES2635713T3
(es)
|
2010-11-01 |
2017-10-04 |
Celgene Car Llc |
Compuestos de heteroarilo y usos de los mismos
|
|
NZ710636A
(en)
|
2010-11-01 |
2017-02-24 |
Celgene Avilomics Res Inc |
Heterocyclic compounds and uses thereof
|
|
WO2012064706A1
(en)
|
2010-11-10 |
2012-05-18 |
Avila Therapeutics, Inc. |
Mutant-selective egfr inhibitors and uses thereof
|
|
WO2012071524A1
(en)
*
|
2010-11-24 |
2012-05-31 |
Ratiopharm Gmbh |
Arylsulfonate salts of fingolimod and processes for preparation thereof
|
|
TW201325593A
(zh)
|
2011-10-28 |
2013-07-01 |
Celgene Avilomics Res Inc |
治療布魯頓（ｂｒｕｔｏｎ’ｓ）酪胺酸激酶疾病或病症之方法
|
|
LT2825042T
(lt)
|
2012-03-15 |
2018-12-10 |
Celgene Car Llc |
Epidermio augimo faktoriaus receptoriaus kinazės slopiklio druskos
|
|
CN104302178B
(zh)
|
2012-03-15 |
2018-07-13 |
西建卡尔有限责任公司 |
表皮生长因子受体激酶抑制剂的固体形式
|
|
EP2935226A4
(en)
|
2012-12-21 |
2016-11-02 |
Celgene Avilomics Res Inc |
HETEROARYL COMPOUNDS AND USES THEREOF
|
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
|
CA2900012A1
(en)
|
2013-02-08 |
2014-08-14 |
Celgene Avilomics Research, Inc. |
Erk inhibitors and uses thereof
|
|
US20150374713A1
(en)
|
2013-02-08 |
2015-12-31 |
Wockhardt Limited |
Stable pharmeceutical composition of amlodipine and benazepril or salts thereof
|
|
BR112015026513A2
(pt)
|
2013-04-17 |
2017-07-25 |
Pfizer |
derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP3179858B1
(en)
|
2014-08-13 |
2019-05-15 |
Celgene Car Llc |
Forms and compositions of an erk inhibitor
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
|
CN104610130A
(zh)
*
|
2015-01-22 |
2015-05-13 |
华东理工常熟研究院有限公司 |
氨氯地平-棕榈酸离子液体及其制备方法和用途
|
|
CN104523588A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-硬脂酸离子液体及其制备方法和用途
|
|
WO2017030893A1
(en)
|
2015-08-14 |
2017-02-23 |
Endocyte, Inc. |
Method of imaging with a chelating compound
|
|
US20180303811A1
(en)
|
2015-10-23 |
2018-10-25 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
|
CN105395495A
(zh)
*
|
2015-11-30 |
2016-03-16 |
宜昌东阳光长江药业股份有限公司 |
一种含有苯磺酸氨氯地平的组合物及其制备方法
|
|
EP3219309A1
(en)
|
2016-03-17 |
2017-09-20 |
K.H.S. Pharma Holding GmbH |
Fixed dosed pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension
|
|
EP3463309B1
(en)
|
2016-05-30 |
2020-06-17 |
Boehringer Ingelheim International GmbH |
Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
|
|
EP3960158B1
(en)
|
2016-10-07 |
2025-05-21 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
|
EP3501502A1
(en)
|
2017-12-20 |
2019-06-26 |
Midas Pharma GmbH |
Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
|
|
EP3773574A4
(en)
|
2018-04-11 |
2022-03-02 |
Silvergate Pharmaceuticals, Inc. |
AMLODIPINE FORMULATIONS
|
|
CN112955965B
(zh)
|
2018-06-14 |
2024-04-09 |
阿斯利康(英国)有限公司 |
使用二氢吡啶类钙通道阻断剂医药组合物降低血压的方法
|
|
FI3911648T3
(fi)
|
2019-01-18 |
2025-01-10 |
Astrazeneca Ab |
6'-[[[(1s,3s)-3-[[5-(difluorometoksi)-2-pyrimidinyyli]amino]syklopentyyli]amino][1(2h),3'-bipyridin]-2-oni pcsk9:n estäjänä ja menetelmät sen käyttöön
|
|
US11253474B1
(en)
|
2021-02-01 |
2022-02-22 |
Liqmeds Worldwide Limited |
Pharmaceutical solution of amlodipine
|
|
EP4052695A1
(en)
|
2021-03-05 |
2022-09-07 |
Midas Pharma GmbH |
Stable oral fixed-dose immediate release pharmaceutical compositions comprising amlodipine, atorvastatin and candesartan cilexetil
|
|
WO2023285646A1
(en)
|
2021-07-15 |
2023-01-19 |
Adamed Pharma S.A |
A pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension
|